Guenther Hochhaus

Guenther Hochhaus Ph.D.

Professor

Department: Pharmaceutics
Business Phone: (352) 273-7861
Business Email: hochhaus@cop.ufl.edu

About Guenther Hochhaus

Hochhaus evaluates anti-asthma drugs in the body (pharmacokinetics) to understand the relationship between the drug properties and the pharmacodynamic effects. His work linking pharmacokinetic-pharmacodynamic approaches with a rational drug delivery design has proven to be a powerful tool in streamlining drug development for inhalation drugs. To provide a strong research program in pharmaceutics and actively seek outside support; to participate in teaching and education of undergraduate, graduate students and postdoctoral associates. The courses include undergraduate class “Principles of Dose Optimization I (PHA 5127)”, and graduate class “Pharmaceutical Analysis I (PHA 6416)”.

Publications

2019 European Journal of Pharmaceutical Sciences
2013 Journal of Aerosol Medicine and Pulmonary Drug Delivery

Grants

October 2019ACTIVE
GSK Fellowship – Jose Francis Year 1
GLAXO SMITHKLINE · Principal Investigator
September 2019ACTIVE
Systematic evaluation of the ex-throat plume properties of MDI formulations
US FOOD AND DRUG ADMN · Principal Investigator
September 2019ACTIVE
A Multiscale Computational Framework for Bioequivalence of Orally Inhaled Drugs
CFD RESEARCH CORP · Principal Investigator
July 2019ACTIVE
Clinical Pharmacokinetics/Dynamics Fellowship 2018-2019 – Sagar Bachav
GLAXO SMITHKLINE · Principal Investigator
July 2018 – July 2019
Clinical Pharmacokinetics/Dynamics Fellowship 2017-2018 – Sagar Bachav
GLAXO SMITHKLINE · Principal Investigator
September 2016 – March 2018
Pharmacokinetic Comparison of Locally Acting Orally Inhaled Drug Products
US FOOD AND DRUG ADMN ·
February 2016 – December 2016
Methacholine stability test over 8 months (months 0-8)-batch 2
COMPLEWARE CORPORATION · Principal Investigator
August 2015 – November 2016
Methacholine Stability Testing with Ion
COMPLEWARE CORPORATION · Principal Investigator
July 2015 – January 2017
Further Characterization of the Modified Chi-square Rati
INTL PHARM AEROSOL CONSRT REG AND SCIENC · Principal Investigator
April 2015ACTIVE
Peptidic Kappa Opioid Receptor Ligands as Potential Treatments for Drug Addiction
NATL INST OF HLTH NIDA · Project Manager
March 2015 – December 2018
Determination of Drug Levels in Interstitial Fluid for Therapeutic IgG by Microdialysis and its Relevance for Pharmacokinetic and Pharmacodynamic
HOFFMANN LA ROCHE · Principal Investigator
December 2014ACTIVE
Comprehensive Evaluation of Formulation Effects on Metered Dose Inhaler Performance
US FOOD AND DRUG ADMN · Principal Investigator
September 2013ACTIVE
Study to Investigate the Sensitivity of Pharmacokinetics in Detecting Differences in Physicochemical Properties of the Active in Suspension Nasal Products for Local Action
US FOOD AND DRUG ADMN ·
September 2013 – December 2016
Stability of Fluticasone Proprionate Capsules for Inhala
FEFA · Principal Investigator
September 2013 – February 2017
Development of In Vivo Predictive Dissolution Method for
US FOOD AND DRUG ADMN · Principal Investigator
August 2012 – July 2017
Does P-glycoprotein Restrict Access of Budesonide but not Fluticasone Propionate to the Placenta and Fetus?
ASTRAZENECA · Principal Investigator
September 2011 – September 2016
Pharmacokinetic Comparison of Locally Acting Inhaled
FEFA · Principal Investigator

Patents

Issued January 2006
Methods for Preparing Coated Drug Particles and Pharmaceutical Formulations Thereof
6,984,404
Issued November 2001
Development of a Bootstrap Application for Resampling Pharmacokinetic and Toxicokinetic Data.
Tu1021748

Education

1984
Ph.D.
University of Munster
1980
B.Sc.
Elisabeth Apotheke

Contact Details

Phones:
Business:
(352) 273-7861
Emails:
Addresses:
Mailing:
PO Box 100494
GAINESVILLE, FL 32610
Physical:
MSB P3-33
MSB P3-33
GAINESVILLE, FL 326110001